Bridge to Transplantation with a Left Ventricular Assist Device.
10.5090/kjtcs.2012.45.2.116
- Author:
Jae Jun JUNG
1
;
Kiick SUNG
;
Dong Seop JEONG
;
Wook Sung KIM
;
Young Tak LEE
;
Pyo Won PARK
Author Information
1. Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea. kiick.sung@samsung.com
- Publication Type:Case Report
- Keywords:
Left ventricular assist device;
Heart failure;
Heart transplantation;
Extracorporeal membrane oxygenation
- MeSH:
Acidosis, Lactic;
Cardiac Output, Low;
Cardiomyopathy, Dilated;
Cytomegalovirus;
Extracorporeal Membrane Oxygenation;
Female;
Follow-Up Studies;
Heart;
Heart Failure;
Heart Transplantation;
Heart Ventricles;
Heart-Assist Devices;
Humans;
Middle Aged;
Oliguria;
Pneumonia;
Rejection (Psychology);
Renal Replacement Therapy;
Transplants;
Tuberculosis, Pulmonary
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2012;45(2):116-119
- CountryRepublic of Korea
- Language:English
-
Abstract:
A 61-year-old female patient was diagnosed with dilated cardiomyopathy with severe left ventricle dysfunction. Two days after admission, continuous renal replacement therapy was performed due to oliguria and lactic acidosis. On the fifth day, an intra-aortic balloon pump was inserted due to low cardiac output syndrome. Beginning 4 days after admission, she was supported for 15 days thereafter with an extracorporeal left ventricular assist device (LVAD) because of heart failure with multi-organ failure. A heart transplant was performed while the patient was stabilized with the LVAD. She developed several complications after the surgery, such as cytomegalovirus pneumonia, pulmonary tuberculosis, wound dehiscence, and H1N1 infection. On postoperative day 19, she was discharged from the hospital with close follow-up and treatment for infection. She received follow-up care for 10 months without any immune rejection reaction.
